Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Interest Expenses (2020 - 2023)

GeneDx Holdings (WGS) has disclosed Interest Expenses for 4 consecutive years, with $626000.0 as the latest value for Q2 2023.

  • On a quarterly basis, Interest Expenses fell 20.76% to $626000.0 in Q2 2023 year-over-year; TTM through Mar 2024 was $626000.0, a 80.23% decrease, with the full-year FY2022 number at $3.2 million, up 13.12% from a year prior.
  • Interest Expenses was $626000.0 for Q2 2023 at GeneDx Holdings, down from $767000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $808000.0 in Q1 2022 to a low of $626000.0 in Q2 2023.
  • A 4-year average of $734818.2 and a median of $723000.0 in 2021 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: increased 18.01% in 2022, then fell 20.76% in 2023.
  • GeneDx Holdings' Interest Expenses stood at $648000.0 in 2020, then increased by 9.1% to $707000.0 in 2021, then grew by 13.58% to $803000.0 in 2022, then dropped by 22.04% to $626000.0 in 2023.
  • Per Business Quant, the three most recent readings for WGS's Interest Expenses are $626000.0 (Q2 2023), $767000.0 (Q1 2023), and $803000.0 (Q4 2022).